North America Acne Medication Market Forecast to 2030 - Regional Analysis by Therapeutic Class, Formulation, Type, Acne Type, and Distribution Channel

The North America acne medication market was valued at US$ 3.36 billion in 2022 and is expected to reach US$ 4.79 billion by 2030; it is estimated to register at a CAGR of 4.6% from 2023 to 2030.

Upsurge in Need for Organic and Natural Treatments Fuels North America Acne Medication Market

As people are becoming more conscious of the potentially harmful effects of synthetic ingredients and chemicals used in traditional skincare products, the demand for natural and organic alternatives that are deemed to be safer, gentler, and more environmentally friendly is on the rise across the world. Consumers are increasingly seeking products free from harsh chemicals, artificial fragrances, and potentially irritating substances, opting for formulations that harness the power of plant-based ingredients, botanical extracts, essential oils, and other natural compounds known for their skincare benefits.

In response to this trend, many skincare brands and manufacturers are developing a wide range of natural and organic acne treatment products that cater to the needs of health-conscious consumers. These products often feature ingredients such as tea tree oil, witch hazel, aloe vera, green tea extract, and salicylic acid derived from natural sources, offering a more holistic and sustainable approach to treating acne without compromising efficacy. In July 2022, MÁDARA, an organic skincare business, introduced two new and natural everyday skincare products - a microbiome-balancing moisturizer and a non-drying face cleanser.

The company claims that these products were developed by blending science and nature, and were specifically formulated to offer gentle treatment for people of different complexions, who are prone to acne. Both products are made with natural, organic, and vegan ingredients - Northern Juniper Stem Cells, fermented polysaccharides, and lichen and Maté tea extracts - which deal specifically with imperfections, keeping the skin unharmed. Adults and teenagers can both utilize this product. Thus, the increasing preference for natural and organic acne treatment options is expected to continue shaping the future of the North America acne medication market in the coming years.

The shift toward natural and organic acne treatment options is also driven by the increasing stringency of regulatory scrutiny and complications associated with industry standards. Regulatory agencies emphasize ingredient transparency, safety, and sustainability, prompting companies to reformulate their products to meet evolving consumer preferences for cleaner and greener skincare solutions. Thus, as more consumers prioritize natural ingredients and eco-friendly formulations in their skincare routines, the North America acne medication market is expected to experience new growth trends in the coming years.

North America Acne Medication Market Overview

The acne medication market in North America is segmented into the US, Canada, and Mexico. The US held the largest North American acne medication market share in 2022. Acne is a skin condition brought on by debris, oil, sebum, and dead skin cells clogging hair follicles. According to the American Academy of Dermatology, acne is the most prevalent illness in the US, up to 50 million Americans suffer from acne each year, making it the most common skin ailment in the country. The acne medication market in this country is projected to expand due to the increased incidence of acne in Americans and the subsequent launch of various innovative acne medications.

North America Acne Medication Market Segmentation

• The North America acne medication market is segmented based on therapeutic class, formulation, type, acne type, and distribution channel, and country.
• Based on therapeutic class, the North America acne medication market is segmented into retinoids, benzoyl peroxide, antibiotics, salicylic acid, and others. The retinoids segment held the largest share in 2022.
• In terms of formulation, the North America acne medication market is bifurcated into topical medication and oral medication. The topical medication segment held a larger largest share in 2022.
• By type, the North America acne medication market is bifurcated into prescription medicine and over-the-counter medicine. The prescription medicine segment held a larger largest share in 2022.
• Based on acne type, the North America acne medication market is bifurcated into non-inflammatory acne and inflammatory acne. The inflammatory acne segment held a larger share in 2022.
• In terms of distribution channel, the North America acne medication market is segmented into pharmacies and drug stores, retail stores, and e-commerce. The pharmacies and drug stores segment held the largest share in 2022.
• Based on country, the North America acne medication market is categorized into US, Canada, and Mexico. The US dominated the North America acne medication market in 2022.
• Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Almirall SA, Johnson & Johnson, Bausch Health Companies Inc, Centro Internacional de Cosmiatria SA de CV, Galderma SA, Pfizer Inc, GSK Plc, Viatris Inc, Somar Sapi De CV, and Italmex SA are some of the leading companies operating in the North America acne medication market.

Market Highlights

• Based on therapeutic class, the North America acne medication market is segmented into retinoids, benzoyl peroxide, antibiotics, salicylic acid, and others. The retinoids segment held 33.5% share of the North America acne medication market in 2022, amassing US$ 1.12 billion. It is projected to garner US$ 1.80 billion by 2030 to expand at 6.2% CAGR during 2023-2030.
• In terms of formulation, the North America acne medication market is bifurcated into topical medication and oral medication. The topical medication segment held 68.7% share of the North America acne medication market in 2022, amassing US$ 2.31 billion. It is estimated to garner US$ 3.41 billion by 2030 to expand at 5.0% CAGR during 2023-2030.
• The prescription medicine segment held 65.2% share of North America acne medication market in 2022, amassing US$ 2.19 billion. It is predicted to garner US$ 3.24 billion by 2030 to expand at 5.1% CAGR during 2023-2030.
• The inflammatory acne segment held 54.7% share of the North America acne medication market in 2022, amassing US$ 1.84 billion. It is projected to garner US$ 2.68 billion by 2030 to expand at 4.9% CAGR during 2023-2030.
• In terms of distribution channel, the North America acne medication market is segmented into pharmacies and drug stores, retail stores, and e-commerce. The pharmacies and drug stores segment held 49.7% share of the North America acne medication market in 2022, amassing US$ 1.67 billion. It is estimated to garner US$ 2.51 billion by 2030 to expand at 5.3% CAGR during 2023-2030.
• The US held 85.6% share of North America acne medication market in 2022, amassing US$ 2.87 billion. It is projected to garner US$ 4.13 billion by 2030 to expand at 4.7% CAGR during 2023-2030.

Reasons to Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America acne medication market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in North America acne medication market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.